XENTRAX Trademark

Trademark Overview

On Tuesday, January 27, 2004, a trademark application was filed for XENTRAX with the United States Patent and Trademark Office. The USPTO has given the XENTRAX trademark a serial number of 79001132. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, November 18, 2019. This trademark is owned by Merck KGaA. The XENTRAX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases, diabetes, and diseases of the central nervous system, excluding tranquilizers, available on prescription only
xentrax

General Information

Serial Number79001132
Word MarkXENTRAX
Filing DateTuesday, January 27, 2004
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateMonday, November 18, 2019
Registration Number3076830
Registration DateTuesday, April 4, 2006
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 30, 2005

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of cardiovascular diseases, diabetes, and diseases of the central nervous system, excluding tranquilizers, available on prescription only

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, November 9, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMerck KGaA
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDarmstadt D64293
DE
Party NameMerck KGaA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDarmstadt D64293
DE
Party NameMerck KGaA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events

Event DateEvent Description
Monday, September 14, 2020UNDELIVERABLE MAIL - NO ACTION TAKEN
Friday, August 28, 2020NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, August 28, 2020DEATH OF INTERNATIONAL REGISTRATION
Friday, June 13, 2014TOTAL INVALIDATION PROCESSED BY THE IB
Wednesday, May 7, 2014TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Tuesday, July 9, 2013TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, November 9, 2012CANCELLED SECTION 71
Friday, December 4, 2009INTERNATIONAL REGISTRATION RENEWED
Friday, November 2, 2007FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, October 31, 2006FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, October 31, 2006FINAL DISPOSITION PROCESSED
Thursday, October 19, 2006FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, April 4, 2006REGISTERED-PRINCIPAL REGISTER
Friday, February 17, 2006EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Thursday, September 22, 2005EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, August 30, 2005PUBLISHED FOR OPPOSITION
Wednesday, August 10, 2005NOTICE OF PUBLICATION
Thursday, May 12, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, April 29, 2005ASSIGNED TO LIE
Thursday, April 28, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 24, 2005REFUSAL PROCESSED BY IB
Thursday, March 17, 2005AMENDMENT FROM APPLICANT ENTERED
Friday, February 18, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 22, 2005PAPER RECEIVED
Friday, February 18, 2005NON-FINAL ACTION MAILED
Thursday, February 10, 2005FAX SENT
Friday, August 20, 2004NON-FINAL ACTION MAILED
Wednesday, August 18, 2004ASSIGNED TO EXAMINER
Wednesday, March 17, 2004NEW APPLICATION ENTERED IN TRAM
Friday, March 12, 2004SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Related Keywords

xentrax diseases excluding system tranquilizers available only prescription nervous central prevention